Table of Contents

Executive Summary

1 Immuno-oncology Drugs Market Overview

• 1.1 Product Overview and Scope of Immuno-oncology Drugs
• 1.2 Immuno-oncology Drugs Segment by Type
  • 1.2.1 Global Immuno-oncology Drugs Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 Immune Checkpoint Inhibitors
  • 1.2.3 Monoclonal Antibodies
  • 1.2.4 Cytokine-Based Immunotherapy
  • 1.2.5 Cancer Vaccines
  • 1.2.6 CAR-T Cell Therapy
• 1.3 Immuno-oncology Drugs Segment by Application
  • 1.3.1 Immuno-oncology Drugs Consumption Comparison by Application (2014-2025)
  • 1.3.2 Hospitals
  • 1.3.3 Pharmacies
  • 1.3.4 Online Pharmacies
• 1.4 Global Immuno-oncology Drugs Market by Region
  • 1.4.1 Global Immuno-oncology Drugs Market Size Region
  • 1.4.2 North America Status and Prospect (2014-2025)
  • 1.4.3 Europe Status and Prospect (2014-2025)
  • 1.4.4 China Status and Prospect (2014-2025)
  • 1.4.5 Japan Status and Prospect (2014-2025)
• 1.5 Global Immuno-oncology Drugs Market Size
  • 1.5.1 Global Immuno-oncology Drugs Revenue (2014-2025)
  • 1.5.2 Global Immuno-oncology Drugs Production (2014-2025)

2 Global Immuno-oncology Drugs Market Competition by Manufacturers

• 2.1 Global Immuno-oncology Drugs Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Immuno-oncology Drugs Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Immuno-oncology Drugs Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Immuno-oncology Drugs Production Sites, Area Served, Product Types
• 2.5 Immuno-oncology Drugs Market Competitive Situation and Trends
  • 2.5.1 Immuno-oncology Drugs Market Concentration Rate
  • 2.5.2 Immuno-oncology Drugs Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Immuno-oncology Drugs Production Market Share by Regions

• 3.1 Global Immuno-oncology Drugs Production Market Share by Regions
• 3.2 Global Immuno-oncology Drugs Revenue Market Share by Regions (2014-2019)
• 3.3 Global Immuno-oncology Drugs Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Immuno-oncology Drugs Production
  • 3.4.1 North America Immuno-oncology Drugs Production Growth Rate (2014-2019)
  • 3.4.2 North America Immuno-oncology Drugs Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Immuno-oncology Drugs Production
  • 3.5.1 Europe Immuno-oncology Drugs Production Growth Rate (2014-2019)
  • 3.5.2 Europe Immuno-oncology Drugs Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Immuno-oncology Drugs Production (2014-2019)
  • 3.6.1 China Immuno-oncology Drugs Production Growth Rate (2014-2019)
  • 3.6.2 China Immuno-oncology Drugs Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Immuno-oncology Drugs Production (2014-2019)
  • 3.7.1 Japan Immuno-oncology Drugs Production Growth Rate (2014-2019)
  • 3.7.2 Japan Immuno-oncology Drugs Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Immuno-oncology Drugs Consumption by Regions

• 4.1 Global Immuno-oncology Drugs Consumption by Regions
• 4.2 North America Immuno-oncology Drugs Consumption (2014-2019)
• 4.3 Europe Immuno-oncology Drugs Consumption (2014-2019)
• 4.4 China Immuno-oncology Drugs Consumption (2014-2019)
• 4.5 Japan Immuno-oncology Drugs Consumption (2014-2019)

5 Global Immuno-oncology Drugs Production, Revenue, Price Trend by Type

• 5.1 Global Immuno-oncology Drugs Production Market Share by Type (2014-2019)
• 5.2 Global Immuno-oncology Drugs Revenue Market Share by Type (2014-2019)
• 5.3 Global Immuno-oncology Drugs Price by Type (2014-2019)
• 5.4 Global Immuno-oncology Drugs Production Growth by Type (2014-2019)

6 Global Immuno-oncology Drugs Market Analysis by Applications

• 6.1 Global Immuno-oncology Drugs Consumption Market Share by Application (2014-2019)
• 6.2 Global Immuno-oncology Drugs Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Immuno-oncology Drugs Business

• 7.1 Amgen, Inc
  • 7.1.1 Amgen, Inc Immuno-oncology Drugs Production Sites and Area Served
  • 7.1.2 Immuno-oncology Drugs Product Introduction, Application and Specification
  • 7.1.3 Amgen, Inc Immuno-oncology Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 AstraZeneca, Plc
  • 7.2.1 AstraZeneca, Plc Immuno-oncology Drugs Production Sites and Area Served
  • 7.2.2 Immuno-oncology Drugs Product Introduction, Application and Specification
  • 7.2.3 AstraZeneca, Plc Immuno-oncology Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 Bristol-Myers Squibb
  • 7.3.1 Bristol-Myers Squibb Immuno-oncology Drugs Production Sites and Area Served
  • 7.3.2 Immuno-oncology Drugs Product Introduction, Application and Specification
  • 7.3.3 Bristol-Myers Squibb Immuno-oncology Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 Celgene Corporation
  • 7.4.1 Celgene Corporation Immuno-oncology Drugs Production Sites and Area Served
  • 7.4.2 Immuno-oncology Drugs Product Introduction, Application and Specification
  • 7.4.3 Celgene Corporation Immuno-oncology Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 Eli Lilly and Company
  • 7.5.1 Eli Lilly and Company Immuno-oncology Drugs Production Sites and Area Served
  • 7.5.2 Immuno-oncology Drugs Product Introduction, Application and Specification
  • 7.5.3 Eli Lilly and Company Immuno-oncology Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 Merck & Co.
  • 7.6.1 Merck & Co. Immuno-oncology Drugs Production Sites and Area Served
  • 7.6.2 Immuno-oncology Drugs Product Introduction, Application and Specification
  • 7.6.3 Merck & Co. Immuno-oncology Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 Hoffmann-La Roche AG
  • 7.7.1 Hoffmann-La Roche AG Immuno-oncology Drugs Production Sites and Area Served
  • 7.7.2 Immuno-oncology Drugs Product Introduction, Application and Specification
  • 7.7.3 Hoffmann-La Roche AG Immuno-oncology Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 Johnson & Johnson
  • 7.8.1 Johnson & Johnson Immuno-oncology Drugs Production Sites and Area Served
  • 7.8.2 Immuno-oncology Drugs Product Introduction, Application and Specification
  • 7.8.3 Johnson & Johnson Immuno-oncology Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 Novartis International AG
  • 7.9.1 Novartis International AG Immuno-oncology Drugs Production Sites and Area Served
  • 7.9.2 Immuno-oncology Drugs Product Introduction, Application and Specification
  • 7.9.3 Novartis International AG Immuno-oncology Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served
• 7.10 AbbVie, Inc.
  • 7.10.1 AbbVie, Inc. Immuno-oncology Drugs Production Sites and Area Served
  • 7.10.2 Immuno-oncology Drugs Product Introduction, Application and Specification
  • 7.10.3 AbbVie, Inc. Immuno-oncology Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.10.4 Main Business and Markets Served
• 7.11 Pfizer Inc.
• 7.12 Sanofi S.A.
• 7.13 EMD Serono, Inc.
• 7.14 Gilead Sciences Inc.
• 7.15 Prometheus Therapeutics & Diagnostics
• 7.16 Aduro BioTech
• 7.17 Galena Biopharma
• 7.18 Bavarian Nordic
• 7.19 Celldex Therapeutics
• 7.20 ImmunoCellular Therapeutics
• 7.21 Incyte

8 Immuno-oncology Drugs Manufacturing Cost Analysis

• 8.1 Immuno-oncology Drugs Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Immuno-oncology Drugs
• 8.4 Immuno-oncology Drugs Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Immuno-oncology Drugs Distributors List
• 9.3 Immuno-oncology Drugs Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Immuno-oncology Drugs Market Forecast

• 11.1 Global Immuno-oncology Drugs Production, Revenue Forecast
  • 11.1.1 Global Immuno-oncology Drugs Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Immuno-oncology Drugs Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Immuno-oncology Drugs Price and Trend Forecast (2019-2025)
• 11.2 Global Immuno-oncology Drugs Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Immuno-oncology Drugs Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Immuno-oncology Drugs Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Immuno-oncology Drugs Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Immuno-oncology Drugs Production, Revenue Forecast (2019-2025)
• 11.3 Global Immuno-oncology Drugs Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Immuno-oncology Drugs Consumption Forecast (2019-2025)
  • 11.3.2 Europe Immuno-oncology Drugs Consumption Forecast (2019-2025)
  • 11.3.3 China Immuno-oncology Drugs Consumption Forecast (2019-2025)
  • 11.3.4 Japan Immuno-oncology Drugs Consumption Forecast (2019-2025)
• 11.4 Global Immuno-oncology Drugs Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Immuno-oncology Drugs Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List

The global Immuno-oncology Drugs market is valued at 49200 million US$ in 2018 is expected to reach 142200 million US$ by the end of 2025, growing at a CAGR of 14.2% during 2019-2025.
This report focuses on Immuno-oncology Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Immuno-oncology Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Amgen, Inc
AstraZeneca, Plc
Bristol-Myers Squibb
Celgene Corporation
Eli Lilly and Company
Merck & Co.
Hoffmann-La Roche AG
Johnson & Johnson
Novartis International AG
AbbVie, Inc.
Pfizer Inc.
Sanofi S.A.
EMD Serono, Inc.
Gilead Sciences Inc.
Prometheus Therapeutics & Diagnostics
Aduro BioTech
Galena Biopharma
Bavarian Nordic
Celldex Therapeutics
ImmunoCellular Therapeutics
Incyte

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Immune Checkpoint Inhibitors
Monoclonal Antibodies
Cytokine-Based Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy

Segment by Application
Hospitals
Pharmacies
Online Pharmacies